Literature DB >> 26067101

Looking below the surface of nicotinic acetylcholine receptors.

Clare Stokes1, Millet Treinin2, Roger L Papke3.   

Abstract

The amino acid sequences of nicotinic acetylcholine receptors (nAChRs) from diverse species can be compared across extracellular, transmembrane, and intracellular domains. The intracellular domains are most divergent among subtypes, yet relatively consistent among species. The diversity indicates that each nAChR subtype has a unique language for communication with its host cell. The conservation across species also suggests that the intracellular domains have defining functional roles for each subtype. Secondary structure prediction indicates two relatively conserved alpha helices within the intracellular domains of all nAChRs. Among all subtypes, the intracellular domain of α7 nAChR is one of the most well conserved, and α7 nAChRs have effects in non-neuronal cells independent of generating ion currents, making it likely that the α7 intracellular domain directly mediates signal transduction. There are potential phosphorylation and protein-binding sites in the α7 intracellular domain, which are conserved and may be the basis for α7-mediated signal transduction.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cys-loop receptors; evolution; intracellular domains; protein structure; proteomics; signal transduction

Mesh:

Substances:

Year:  2015        PMID: 26067101      PMCID: PMC4532579          DOI: 10.1016/j.tips.2015.05.002

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  86 in total

1.  The long internal loop of the alpha 3 subunit targets nAChRs to subdomains within individual synapses on neurons in vivo.

Authors:  B M Williams; M K Temburni; M S Levey; S Bertrand; D Bertrand; M H Jacob
Journal:  Nat Neurosci       Date:  1998-11       Impact factor: 24.884

2.  Nicotinic acetylcholine receptor at 4.6 A resolution: transverse tunnels in the channel wall.

Authors:  A Miyazawa; Y Fujiyoshi; M Stowell; N Unwin
Journal:  J Mol Biol       Date:  1999-05-14       Impact factor: 5.469

3.  Identification of the mouse muscle 43,000-dalton acetylcholine receptor-associated protein (RAPsyn) by cDNA cloning.

Authors:  D E Frail; L L McLaughlin; J Mudd; J P Merlie
Journal:  J Biol Chem       Date:  1988-10-25       Impact factor: 5.157

4.  Trafficking of alpha4* nicotinic receptors revealed by superecliptic phluorin: effects of a beta4 amyotrophic lateral sclerosis-associated mutation and chronic exposure to nicotine.

Authors:  Christopher I Richards; Rahul Srinivasan; Cheng Xiao; Elisha D W Mackey; Julie M Miwa; Henry A Lester
Journal:  J Biol Chem       Date:  2011-07-18       Impact factor: 5.157

5.  Acetylcholine receptor channel imaged in the open state.

Authors:  N Unwin
Journal:  Nature       Date:  1995-01-05       Impact factor: 49.962

6.  Identification of sequence motifs that target neuronal nicotinic receptors to dendrites and axons.

Authors:  Jian Xu; Yongling Zhu; Stephen F Heinemann
Journal:  J Neurosci       Date:  2006-09-20       Impact factor: 6.167

7.  RIC-3 enhances functional expression of multiple nicotinic acetylcholine receptor subtypes in mammalian cells.

Authors:  Stuart J Lansdell; Veronica J Gee; Patricia C Harkness; Anne I Doward; Elizabeth R Baker; Alasdair J Gibb; Neil S Millar
Journal:  Mol Pharmacol       Date:  2005-08-24       Impact factor: 4.436

8.  Ric-3 promotes alpha7 nicotinic receptor assembly and trafficking through the ER subcompartment of dendrites.

Authors:  John K Alexander; Daphna Sagher; Arcadius V Krivoshein; Manuel Criado; Gregory Jefford; William N Green
Journal:  J Neurosci       Date:  2010-07-28       Impact factor: 6.167

9.  Functional modulation of the nicotinic acetylcholine receptor by tyrosine phosphorylation.

Authors:  J F Hopfield; D W Tank; P Greengard; R L Huganir
Journal:  Nature       Date:  1988-12-15       Impact factor: 49.962

10.  New and continuing developments at PROSITE.

Authors:  Christian J A Sigrist; Edouard de Castro; Lorenzo Cerutti; Béatrice A Cuche; Nicolas Hulo; Alan Bridge; Lydie Bougueleret; Ioannis Xenarios
Journal:  Nucleic Acids Res       Date:  2012-11-17       Impact factor: 16.971

View more
  37 in total

1.  Critical Molecular Determinants of α7 Nicotinic Acetylcholine Receptor Allosteric Activation: SEPARATION OF DIRECT ALLOSTERIC ACTIVATION AND POSITIVE ALLOSTERIC MODULATION.

Authors:  Nicole A Horenstein; Roger L Papke; Abhijit R Kulkarni; Ganesh U Chaturbhuj; Clare Stokes; Khan Manther; Ganesh A Thakur
Journal:  J Biol Chem       Date:  2016-01-07       Impact factor: 5.157

2.  Identification of α7 Nicotinic Acetylcholine Receptor Silent Agonists Based on the Spirocyclic Quinuclidine-Δ2 -Isoxazoline Scaffold: Synthesis and Electrophysiological Evaluation.

Authors:  Marta Quadri; Carlo Matera; Almin Silnović; Maria Chiara Pismataro; Nicole A Horenstein; Clare Stokes; Roger L Papke; Clelia Dallanoce
Journal:  ChemMedChem       Date:  2017-06-12       Impact factor: 3.466

Review 3.  Proteins and chemical chaperones involved in neuronal nicotinic receptor expression and function: an update.

Authors:  Arianna Crespi; Sara Francesca Colombo; Cecilia Gotti
Journal:  Br J Pharmacol       Date:  2017-04-19       Impact factor: 8.739

Review 4.  Cholinergic modulation of the immune system presents new approaches for treating inflammation.

Authors:  Donald B Hoover
Journal:  Pharmacol Ther       Date:  2017-05-18       Impact factor: 12.310

5.  B-973, a Novel α7 nAChR Ago-PAM: Racemic and Asymmetric Synthesis, Electrophysiological Studies, and in Vivo Evaluation.

Authors:  Sumanta Garai; Krishnamohan S Raja; Roger L Papke; Jeffrey R Deschamps; M Imad Damaj; Ganesh A Thakur
Journal:  ACS Med Chem Lett       Date:  2018-10-11       Impact factor: 4.345

6.  Reviewing the Diverse Effects of Protein Phosphorylation in Neural Signaling Transduction.

Authors:  Abby K Scurfield
Journal:  J Undergrad Neurosci Educ       Date:  2018-06-15

7.  The α7 nicotinic receptor dual allosteric agonist and positive allosteric modulator GAT107 reverses nociception in mouse models of inflammatory and neuropathic pain.

Authors:  Deniz Bagdas; Jenny L Wilkerson; Abhijit Kulkarni; Wisam Toma; Shakir AlSharari; Zulfiye Gul; Aron H Lichtman; Roger L Papke; Ganesh A Thakur; M Imad Damaj
Journal:  Br J Pharmacol       Date:  2016-07-18       Impact factor: 8.739

Review 8.  Progress in nicotinic receptor structural biology.

Authors:  Anant Gharpure; Colleen M Noviello; Ryan E Hibbs
Journal:  Neuropharmacology       Date:  2020-04-07       Impact factor: 5.250

9.  Anti-inflammatory Silent Agonists.

Authors:  Nicole A Horenstein; Roger L Papke
Journal:  ACS Med Chem Lett       Date:  2017-09-26       Impact factor: 4.345

10.  NS6740, an α7 nicotinic acetylcholine receptor silent agonist, disrupts hippocampal synaptic plasticity.

Authors:  Roger L Papke; Can Peng; Ashok Kumar; Clare Stokes
Journal:  Neurosci Lett       Date:  2018-04-19       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.